Kymera Therapeutics
KYMR
#1949
Rank
A$14.87 B
Marketcap
A$174.21
Share price
-3.42%
Change (1 day)
70.37%
Change (1 year)

EPS for Kymera Therapeutics (KYMR)

EPS in 2026 (TTM): A-$5.27

According to Kymera Therapeutics's latest financial reports the company's current EPS (TTM) is A-$5.47. In 2025 the company made an earnings per share (EPS) of A-$5.56 a decrease over its 2024 EPS that were of A-$4.49.

EPS history for Kymera Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$5.27-5.19%
2025A-$5.5623.91%
2024A-$4.4917.86%
2023A-$3.81-12.5%
2022A-$4.3539.81%
2021A-$3.1122.84%
2020A-$2.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.04-62.71%๐Ÿ‡บ๐Ÿ‡ธ USA